Results 41 to 50 of about 11,219 (248)

Pure red cell aplasia and seronegative myasthenia gravis in association with thymoma

Journal of Community Hospital Internal Medicine Perspectives, 2020
Pure red cell aplasia is an uncommon paraneoplastic syndrome of thymoma. Myasthenia gravis is the most common paraneoplastic syndrome associated with thymoma. We present a case of a 79-year-old Pacific Islander female who presented with profound fatigue,
Sun Yong Lee, Amandeep Gill, Syung Min Jung   +2 more
doaj   +1 more source

Design of and Early Insights From a Generalized Myasthenia Gravis Patient Engagement Research Council

Health Science Reports
Background and Aims An exploratory focus group study was conducted to better understand the needs of patients living with generalized myasthenia gravis (gMG).
Gabrielle Geonnotti, Jacqueline Pesa, Wesley Peters, Melina Taylor, Zia Choudhry, Oluyemisi Falope, Marquetta Price, Lucy Baxter, Bruce West, Lisa Shea   +9 more
doaj   +1 more source

Zytux in Refractory Myasthenia Gravis: A Multicenter, Open-Labeled, Clinical Trial Study of Effectiveness and Safety of a Rituximab Biosimilar

Frontiers in Neurology, 2021
Objectives: Myasthenia gravis (MG) is an immune-mediated neuromuscular disorder responsive to immunomodulatory treatments. 10–20% of MGs are not responsive to conventional first-line therapies.
Farzad Fatehi, Kamyar Moradi, Ali Asghar Okhovat, Ali Asghar Okhovat, Ghazaleh Shojatalab, Behnaz Sedighi, Reza Boostani, Payam Sarraf, Payam Sarraf, Bahram Haghi Ashtiani, Majid Ghasemi, Soussan Moussavi, Nassim Anjidani, Shahriar Nafissi   +13 more
doaj   +1 more source

a pilot study [PDF]

, 2015
Muscular weakness in myasthenia gravis (MG) is commonly assessed using Quantitative Myasthenia Gravis Score (QMG). More objective and quantitative measures may complement the use of clinical scales and might detect subclinical affection of muscles.
Brandt, Alexander U., Hoffmann, Sarah, Kohler, Siegfried, Meisel, Andreas, Paul, Friedemann, Piper, Sophie K., Reilmann, Ralf, Sass, Christian, Siedler, Jana   +8 more
core   +1 more source

Case Report : Generalized Myasthenia Gravis

Medicinus, 2020
Generalized myasthenia gravis is a rare case of autoimmune wherein the antibodies destroy the post-sinaptic acetylcholine receptors at skeletal muscle’s neuromuscular junctions. The clinical presentation is specific distributin of motoric deficit without sensoric deficit which diminished with rest and worsens with excessive use.
Devita Widjaja, Vivien Puspitasari
openaire   +2 more sources

Initial Repetitive Nerve Stimulation Test Predicts Conversion of Ocular Myasthenia Gravis to Generalized Myasthenia Gravis

Journal of Clinical Neurology, 2021
A major concern with ocular myasthenia gravis (MG) is the potential conversion to generalized MG. This study was conducted to determine if the repetitive nerve stimulation (RNS) test could predict the conversion from ocular to generalized MG.The RNS test was conducted in a consistent manner on five muscles in the face and limbs in every patient ...
Ki Hoon Kim, Seung Woo Kim, Ha Young Shin   +2 more
openaire   +3 more sources

Клініко-імунологічні співставлення у хворих на міастенію [PDF]

, 2018
Було проведено клініко-неврологічне обстеження та визначення антитіл до рецепторів ацетилхоліну та м’язово-специфічної тирозин-кінази у 96 хворих на міастенію (71 – з генералізованою, 25 – з очною формою). Встановлено, що у хворих на генералізовану
Кальбус, О.І.
core   +1 more source

Anestesia peridural torácica para cirugía plástica de mama en paciente portadora de miastenia gravis: relato de caso [PDF]

, 2005
BACKGROUND AND OBJECTIVES: Myasthenia gravis is a chronic autoimmune disease characterized by skeletal muscles weakness promoted by decreased acetylcholine receptors in the neuromuscular junction.
Barbosa, Fabiano Timbó, Cavalcanti, Ismar Lima, Correia, Marta Cristiane Bezerra, Cunha, Rafael Martins Da   +3 more
core   +5 more sources

An update on treatments in myasthenia gravis [PDF]

, 2016
This month, we discuss three papers which publish the results of trials into potential treatment approaches to myasthenia gravis (MG). When treatment with cholinesterase inhibitors alone fails to control symptoms, treatment with steroids may be required,
Lliwen A. Jones, Neil P. Robertson
core   +4 more sources

Clinical profile and quality of life in myasthenia gravis using MGQOL15 R(Hindi): An Indian perspective

Annals of Indian Academy of Neurology, 2023
Background: Myasthenia Gravis (MG) is a chronic fluctuating illness, due to the dysfunction of neuromuscular junction which is autoimmune in nature. The disease severely affects the Quality Of Life (QOL). Objective: The primary objective of our study was
Ganeshgouda Majigoudra, Ashish K Duggal, Debashish Chowdhury, Arun Koul, Vineet K Todi, Sujata Roshan   +5 more
doaj   +1 more source